99% Cured of Hep C in Abbott’s Interferon-Free Regimen
October 19, 2012
Abbott’s Hepatitis C Drugs Clear Virus in 99% of Patients
By Ryan Flinn and Drew Armstrong on October 15, 2012
An experimental drug combination from Abbott Laboratories (ABT) wiped out all traces of the virus that causes hepatitis C in 99 percent of patients with the liver disease, a study showed.
The 571 patients in the trial took a two- or three-drug mixture of Abbott therapies for 8 to 24 weeks, along with the antiviral ribavirin. A 79-patient group on the combination of three medicines plus ribavirin for 12 weeks responded best, the Abbott Park, Illinois-based company said today in a statement.
Continue reading this entire article:
Can Frankincense Help Defeat Hepatitis C?
Novel Hep C Strategy Aimed at Host Cells